What does CUSIP 218352102 represent in this 13F holders report?

CUSIP 218352102 is the security identifier for CORT - CORCEPT THERAPEUTICS INC - Common Stock used to aggregate holder disclosures.

How many institutions held CORT - CORCEPT THERAPEUTICS INC - Common Stock in Q2 2018?

212 institutional investors reported CORT - CORCEPT THERAPEUTICS INC - Common Stock for Q2 2018. Use the holders table for investor-level position and value details.

CORCEPT THERAPEUTICS INC - Common Stock (CORT)

CUSIP: 218352102

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock
Shares outstanding: 105,274,735
Total 13F shares: 87,598,857
Share change: -275,467
Total reported value: $1,376,792,174
Put/Call ratio: 470%
Price per share: $15.72
Number of holders: 212
Value change: -$4,897,891
Number of buys: 104
Number of sells: 95

Quarterly Holders Quick Answers

What is CUSIP 218352102?
CUSIP 218352102 identifies CORT - CORCEPT THERAPEUTICS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 218352102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CORT - CORCEPT THERAPEUTICS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	12%	12,905,164	$212,288,000	—	31 Mar 2018	13F
FEDERATED HERMES, INC.	13F	Company	12%	12,686,727	$208,697,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	8.3%	8,751,268	$143,958,000	—	31 Mar 2018	13F
INGALLS & SNYDER LLC	13F	Company	6.5%	6,817,540	$112,149,000	—	31 Mar 2018	13F
Consonance Capital Management LP	13F	Company	4.9%	5,188,417	$85,349,000	—	31 Mar 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	4.6%	4,798,500	$78,935,000	—	31 Mar 2018	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	3.1%	3,314,569	$54,522,000	—	31 Mar 2018	13F
STATE STREET CORP	13F	Company	3%	3,136,704	$51,596,000	—	31 Mar 2018	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.5%	1,576,649	$25,936,000	—	31 Mar 2018	13F
Invesco Ltd.	13F	Company	1.5%	1,536,670	$25,278,000	—	31 Mar 2018	13F
Bank of New York Mellon Corp	13F	Company	1.1%	1,186,951	$19,526,000	—	31 Mar 2018	13F
NORTHERN TRUST CORP	13F	Company	1.1%	1,116,603	$18,368,000	—	31 Mar 2018	13F
NEXTHERA CAPITAL LP	13F	Company	0.99%	1,045,196	$17,193,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.83%	878,255	$14,447,000	—	31 Mar 2018	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.81%	850,503	$13,989,000	—	31 Mar 2018	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	0.79%	836,280	$13,757,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	0.74%	783,317	$12,885,000	—	31 Mar 2018	13F
Russell Investments Group, Ltd.	13F	Company	0.74%	782,814	$12,878,000	—	31 Mar 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.74%	781,580	$12,855,000	—	31 Mar 2018	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.74%	780,700	$12,843,000	—	31 Mar 2018	13F
AMI ASSET MANAGEMENT CORP	13F	Company	0.67%	709,300	$11,668,000	—	31 Mar 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.57%	601,408	$9,893,000	—	31 Mar 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.57%	599,857	$9,868,000	—	31 Mar 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.54%	566,602	$9,321,000	—	31 Mar 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.5%	524,900	$8,635,000	—	31 Mar 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.47%	490,663	$8,072,000	—	31 Mar 2018	13F
NORGES BANK	13F	Company	0.45%	475,761	$7,826,000	—	31 Mar 2018	13F
OAK RIDGE INVESTMENTS LLC	13F	Company	0.42%	441,168	$7,257,000	—	31 Mar 2018	13F
ESSEX INVESTMENT MANAGEMENT CO LLC	13F	Company	0.41%	434,624	$7,150,000	—	31 Mar 2018	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.41%	429,873	$7,071,000	—	31 Mar 2018	13F
S&T BANK/PA	13F	Company	0.4%	426,257	$7,012,000	—	31 Mar 2018	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.4%	426,082	$7,009,000	—	31 Mar 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.34%	362,930	$5,970,000	—	31 Mar 2018	13F
FMR LLC	13F	Company	0.34%	353,395	$5,813,000	—	31 Mar 2018	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.33%	347,748	$5,720,000	—	31 Mar 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	0.32%	331,950	$5,461,000	—	31 Mar 2018	13F
Squarepoint Ops LLC	13F	Company	0.31%	327,591	$5,389,000	—	31 Mar 2018	13F
Marshall Wace North America L.P.	13F	Company	0.31%	321,264	$5,285,000	—	31 Mar 2018	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.28%	290,991	$4,787,000	—	31 Mar 2018	13F
DENALI ADVISORS LLC	13F	Company	0.23%	246,200	$4,050,000	—	31 Mar 2018	13F
Timpani Capital Management LLC	13F	Company	0.23%	245,279	$4,035,000	—	31 Mar 2018	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.23%	238,451	$3,924,000	—	31 Mar 2018	13F
CITADEL ADVISORS LLC	13F	Company	0.22%	233,249	$3,837,000	—	31 Mar 2018	13F
JPMORGAN CHASE & CO	13F	Company	0.22%	227,758	$3,747,000	—	31 Mar 2018	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.21%	222,510	$3,660,000	—	31 Mar 2018	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.2%	215,000	$3,537,000	—	31 Mar 2018	13F
AJ WEALTH STRATEGIES, LLC	13F	Company	0.2%	206,620	$3,399,000	—	31 Mar 2018	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.19%	199,745	$3,286,000	—	31 Mar 2018	13F
Legal & General Group Plc	13F	Company	0.19%	195,352	$3,177,000	—	31 Mar 2018	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.18%	192,182	$3,161,000	—	31 Mar 2018	13F

Institutional Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q2 2018

As of 30 Jun 2018, CORCEPT THERAPEUTICS INC - Common Stock (CORT) was held by 212 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 87,598,857 shares. The largest 10 holders included BlackRock Inc., FEDERATED INVESTORS INC /PA/, VANGUARD GROUP INC, INGALLS & SNYDER LLC, Consonance Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, ACADIAN ASSET MANAGEMENT LLC, Invesco Ltd., and DIMENSIONAL FUND ADVISORS LP. This page lists 212 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

210

Q2 2018 holders

212

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.